Dr. Reddy’s Laboratories (EU) Ltd | Reg: 02177715 | Created: 1987-10-13 | Status: active | Type: Ltd Dr. Reddy’s Laboratories (EU) Ltd is a global pharmaceutical company specializing in the research, development, manufacturing, and marketing of active pharmaceutical ingredients (APIs) and finished dosage forms. Established in 1987, the company operates as a wholly-owned subsidiary of Dr. Reddy’s Laboratories, Inc., a publicly traded pharmaceutical enterprise based in Hyderabad, India. The company’s core business focuses on the production of generic and innovative pharmaceutical products, primarily within the cardiovascular, anti-infective, and gastrointestinal therapeutic areas. Dr. Reddy’s Laboratories (EU) Ltd maintains a significant international presence, with operations spanning across Europe, North America, and Asia. The company’s strategic focus is on providing affordable and high-quality medicines to patients worldwide. Dr. Reddy’s Laboratories (EU) Ltd’s operations are underpinned by robust research and development capabilities, leveraging a global network of scientists and engineers. The company actively monitors market trends, competitor activities, and evolving regulatory landscapes to maintain a competitive edge. It is a global business with a strong emphasis on innovation and strategic partnerships. SIC Codes: - 21100: Manufacture of basic pharmaceutical products. The company’s website provides detailed information on its technical research, competitor analysis, market insights, company profile, and stock symbol.

Dr. Reddy’s Laboratories (EU) Ltd | Reg: 02177715 | Created: 1987-10-13 | Status: active | Type: Ltd Dr. Reddy’s Laboratories (EU) Ltd is a global pharmaceutical company specializing in the research, development, manufacturing, and marketing of active pharmaceutical ingredients (APIs) and finished dosage forms. Established in 1987, the company operates as a wholly-owned subsidiary of Dr. Reddy’s Laboratories, Inc., a publicly traded pharmaceutical enterprise based in Hyderabad, India. The company’s core business focuses on the production of generic and innovative pharmaceutical products, primarily within the cardiovascular, anti-infective, and gastrointestinal therapeutic areas. Dr. Reddy’s Laboratories (EU) Ltd maintains a significant international presence, with operations spanning across Europe, North America, and Asia. The company’s strategic focus is on providing affordable and high-quality medicines to patients worldwide. Dr. Reddy’s Laboratories (EU) Ltd’s operations are underpinned by robust research and development capabilities, leveraging a global network of scientists and engineers. The company actively monitors market trends, competitor activities, and evolving regulatory landscapes to maintain a competitive edge. It is a global business with a strong emphasis on innovation and strategic partnerships. SIC Codes: - 21100: Manufacture of basic pharmaceutical products. The company’s website provides detailed information on its technical research, competitor analysis, market insights, company profile, and stock symbol.